# VitaFlow™ Transcatheter Aortic Valve System Pre-market Trial

> **NCT04655742** · NA · UNKNOWN · sponsor: **Shanghai MicroPort CardioFlow Medtech Co., Ltd.** · enrollment: 120 (actual)

## Conditions studied

- Aortic Valve Stenosis

## Interventions

- **DEVICE:** VitaFlow™ Transcatheter Aortic Valve System

## Key facts

- **NCT ID:** NCT04655742
- **Lead sponsor:** Shanghai MicroPort CardioFlow Medtech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-06-27
- **Primary completion:** 2017-09-06
- **Final completion:** 2021-12-31
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2020-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04655742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04655742, "VitaFlow™ Transcatheter Aortic Valve System Pre-market Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04655742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*